- US12594277utility2026Macrocyclic ULK1/2 Inhibitors0 cites
- US12590336utility2026Role of PVT1 in the Diagnosis and Treatment of Myc-driven Cancer0 cites
- US12534729utility2026Uses of Synthetic Lethal Partners for Treatment of Cancer0 cites
- US12398179utility2025Nanomolar Peptides and Derivatives to Differentially Modulate Ephrin Receptors0 cites
- US12365659utility2025Non-polyamine Based Polyamine Transport Inhibitors and Their Use in the Treatment of Human Cancers0 cites
- US12338495utility2025Methods of Diagnosing and Treating Alzheimer's Disease0 cites
- US12319684utility2025Agonists of the Apelin Receptor and Methods of Use Thereof0 cites
- US12290569utility2025Methods and Compositions Using Peptides and Proteins with C-terminal Elements0 cites
- US12285392utility2025Method for Modulating Metabolism0 cites
- US12263159utility2025Fused Ring Compound Having Urea Structure0 cites
- US12239656utility2025Nucleoporins as Drug Targets for Anti-proliferative Therapeutics0 cites
- US12223643utility2025Machine-learning System for Diagnosing Disorders and Diseases and Determining Drug Responsiveness0 cites
- US12195558utility2025Targeted Delivery System and Methods of Use Therefor0 cites
- US12090249utility2024Implant and Coating to Reduce Osteolysis0 cites
- US12071413utility2024Azole Derivatives as Apelin Receptor Agonist0 cites
- US12071414utility2024Apelin Receptor Agonists and Methods of Use Thereof0 cites
- US12030896utility2024Pikfyve Inhibitors0 cites
- US12023389utility2024Compositions That Target Tumor-associated Macrophages and Methods of Use Therefor0 cites
- US12006321utility2024Substituted Pyrazolo[1,5-a]pyrimidines as Apelin Receptor Agonists0 cites
Page 1 of 2Next →